跳至主要内容
临床试验/JPRN-jRCTs052180059
JPRN-jRCTs052180059已完成1 期

Safety of Flash Sensor-based Glucose Monitoring in Allogeneic Hematopoietic Stem Cell Transplantation Recipients - FGM-SCT P1 Study

MINAMI Hironobu0 个研究点目标入组 8 人开始时间: 2019年2月14日最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
8

研究概览

简要总结

Our study suggests that FreeStyle Libre Pro can be used safely in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). However, glucose levels in tissue interstitial fluid are often lower than those in blood glucose. Therefore, we should pay attention for interpreting glucose levels in tissue interstitial fluid obtained by FreeStyle Libre Pro in HSCT patients.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 69age old(—)
性别
All

入选标准

  • (1)Patients who are at least 20 and under 70 years of age
  • (2)Patients who will undergo allogeneic hematopoietic stem cell transplantation
  • (3)Patients who sign a written informed consent
  • (4)Patients who have never used FreeStyle LibrePro

排除标准

  • (1)Patients who will undergo HLA haplo-identical stem cell transplantation
  • (2)Patients who need to perform X-ray or CT scan more than once a week
  • (3)Patients who have infection on their upper arms for sensor sites
  • (4)Patients who contact dermatitis
  • (5)Patients who cannot use alcohol and chlorhexidine gluconate for sterilization
  • (6)Patients who have implanted medical devices
  • (7)Patients judged inappropriate perticipants for this study by their attending doctors

研究者

发起方
MINAMI Hironobu

相似试验